skip to main content

How to find effective natural compounds faster

Heike Brötz-Oesterhelt, CMFI's deputy spokesperson, on how to find natural compounds more quickly. A balance sheet for 2021 and current research goals of natural product research in Tübingen.

05.10.2022 CMFI News

The research group of Prof. Heike Brötz-Oesterhelt from the Interfaculty Institute of Microbiology and Infection Medicine at the Eberhard Karls University of Tübingen is looking for new antibacterial agents. A major challenge in today's natural product research is to discover and screen out already known substances at an early stage in order to have capacities for researching new active substances.

"We need information on bioactivity and mode of action as early as possible in order to focus on isolating compounds with unknown modes of action."– Heike Brötz-Oesterhelt

To this end, the researchers have developed a new bioreporter approach, which they have published in the journal Cell Chemical Biology. Bioreporters are microbial cells that have been genetically modified to produce a measurable signal in response to a specific agent in their environment - in this case, a color circle. This allows information on the mode of action of bioactive compounds to be generated as early as the primary screening stage, without the need to enrich or purify the substance. The method works along the entire purification pipeline, i.e. with culture supernatants, extracts, fractions and pure substances. Combined with high-resolution mass spectrometry, the biosensor panel is an efficient and sensitive tool for deciphering compounds. It immediately informs about the inhibited metabolic pathway, allowing the selection of targeted follow-up assays to elucidate the molecular target.

 

Balance 2021:

  •     In corallopyronin A development, completion of transfer to industrial Clinical Research Organizations and upscaling of production to large scale (15,000 liters), and pivotal tox studies in dogs. (partially implemented)
  •     Elaboration and publication of a roadmap of antibiotic development from translational academic research as part of DZIF participation in JPI-AMR.
  •     Demonstration/confirmation of in vivo proof-of-concept for supportive therapy of Pseudomonas aeruginosa infections using PqsR-inverse agonistsin combination with an aminoglycoside antibiotic.

Current projects:

  •     Demonstrate/confirm in vivo proof-of-concept for adjuvant therapy of Pseudomonas aeruginosa infections by using LecB inhibitors in combination with a standard-of-care antibiotic.
  •     Nomination of a lead structure for use against Pseudomonas aeruginosa infections.
  •     Identification and use of key transcriptional regulators to activate silent gene clusters and identify novel antibiotically active natural products.


(Text: DZIF Annual Report 2021; Translation: Leon Kokkoliadis)

More Information

New bioreporter approach increases chances of discovering unknown bioactive compounds

CMFI News, 30.03.2021

 

Bioreporters for direct mode of action-informed screening of antibiotic producer strains

Wex K W, Saur J S, Handel F, Ortlieb N, Mokeev VKulik A, Niedermeyer T H J, Mast Y, Grond S, Berscheid A, Brötz-Oesterhelt H. CellChemBio (2021), doi: 10.1016/j.chembiol.2021.02.022.

Scientific Contact

Prof. Dr. Heike Brötz-Oesterhelt

Deputy Spokesperson CMFI

University of Tübingen
Interfaculty Institute of Microbiology and Infection Medicine
Department of Microbial Bioactive Compounds

Email: heike.broetz-oesterhelt@uni-tuebingen.de

Website

 

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707
E-Mail: leon.kokkoliadis@uni-tuebingen.de

Related News

New bioreporter approach increases chances of discovering unknown bioactive compounds
30.03.2021 New bioreporter approach increases chances of discovering unknown bioactive compounds CMFI News
New combination of methods shortens search for bioactive compounds
08.08.2022 New combination of methods shortens search for bioactive compounds Press Release
"Hope for New Drugs Arises from the Sea"
01.08.2022 "Hope for New Drugs Arises from the Sea" In the Media

Scientific American

Only 3% of potential bacterial drug sources known
02.05.2022 Only 3% of potential bacterial drug sources known CMFI News
"Den körpereigenen Schutzschild aktivieren"
17.09.2021 "Den körpereigenen Schutzschild aktivieren" In the Media

Schwäbisches Tagblatt

55

Related Articles

Decoding new gene functions in the human gut microbiome
26.03.2024 – 26.03.2024 Decoding new gene functions in the human gut microbiome CMFI News
Volkswagen Foundation funds project to convert waste into new biomaterials
14.02.2024 Volkswagen Foundation funds project to convert waste into new biomaterials CMFI News
Exploring hidden members in microbial communities
05.02.2024 Exploring hidden members in microbial communities CMFI News
Antibiotics highjack bacterial immunity
19.01.2024 Antibiotics highjack bacterial immunity Press Release
Novel antibiotic substance from the human nose
18.12.2023 Novel antibiotic substance from the human nose Press Release
Unraveling the Impact of Xenobiotics on Gut Microbiota: A High-Throughput Approach under Anaerobic Conditions
13.12.2023 Unraveling the Impact of Xenobiotics on Gut Microbiota: A High-Throughput Approach under Anaerobic Conditions In the Media
"Mikrobiom – Schlüssel zur Gesundheit?"
08.12.2023 "Mikrobiom – Schlüssel zur Gesundheit?" In the Media

Planet Wissen

The Frankenstein molecule: resurrecting an ancient antibiotic to create antibiotics of the future
30.11.2023 The Frankenstein molecule: resurrecting an ancient antibiotic to create antibiotics of the future In the Media

Nature - Behind the paper

Taking antibiotics back in time
30.11.2023 Taking antibiotics back in time Press Release
Welche Rolle spielen Darmbakterien bei der Krebsimmuntherapie?
23.11.2023 Welche Rolle spielen Darmbakterien bei der Krebsimmuntherapie? Press Release
Andreas Peschel at Deutschlandfunk Kultur “Zeitfragen” Podcast
16.11.2023 Andreas Peschel at Deutschlandfunk Kultur “Zeitfragen” Podcast In the Media

Deutschlandfunk Kultur

“Wie unsere Nase unsere Immunantwort beeinflusst”
04.11.2023 “Wie unsere Nase unsere Immunantwort beeinflusst” In the Media

radioeins/RBB

Unique nasal microbiome
25.10.2023 Unique nasal microbiome Press Release
CRISPR maps temperature-sensitive mutations in E. coli
12.10.2023 CRISPR maps temperature-sensitive mutations in E. coli CMFI News
New study advocates remission as therapeutic goal in prediabetes
26.09.2023 New study advocates remission as therapeutic goal in prediabetes Press Release
Potatos with the right antennae
06.09.2023 Potatos with the right antennae Press Release
Lukas Mager receives ERC Starting Grant
05.09.2023 Lukas Mager receives ERC Starting Grant Press Release
Biosurfactants might offer an environmentally friendly solution for tackling oil spills
21.07.2023 Biosurfactants might offer an environmentally friendly solution for tackling oil spills Press Release